Data for: Insight into the mechanism of action of EP-39, a bevirimat derivative that inhibits HIV-1 maturation

Published: 3 March 2019| Version 1 | DOI: 10.17632/93ngk2rn74.1
Nathalie Chazal,
Laurence Briant,
Serge Turcaud,
Pascale Coric,
Philippe LAUGAA,
Aymeric Neyret,
Serge Bouaziz,
Anaïs Cransac,
Bernard Gay


In silico docking of BVM and EP-39 on the hexameric crystal structure of the CACTD-SP1 Gag fragment